Breaking News Instant updates and real-time market news.

GD

General Dynamics

$173.09

-11.91 (-6.44%)

09:23
10/25/18
10/25
09:23
10/25/18
09:23

General Dynamics price target lowered to $216 from $229 at Credit Suisse

Credit Suisse analyst Robert Spingarn lowered his price target for General Dynamics to $216 from $229 as softer sales and questions on 2019 drive selloff in the shares. The analyst reiterates an Outperform rating on the shares.

GD General Dynamics
$173.09

-11.91 (-6.44%)

09/21/18
MSCO
09/21/18
NO CHANGE
MSCO
Morgan Stanley says not to panic over Defense payment proposal
Morgan Stanley analyst Rajeev Lalwani attributes the underperformance in Defense stocks over the last two days compared to the broader market to heightened concerns around a month old proposal from the Department of Defense to adjust progress and performance payments down to 50% from 80% of cost, which would effectively slow the timing of cash flow receipts closer to when a project is complete. He sees a number of reasons not to panic, firstly because he believes that the Administration will not move forward with a proposal industry-players will paint as being anti-business and anti-defense spending. Even if it were to move forward, the proposal primarily impacts cash flow timing, with underlying earnings unchanged and potential offsets evident, Lalwani tells investors. Lastly, while there would be considerable uncertainty around rule implementation, the proposal would create a path to superior cash flows versus today, the analyst added. Companies in the defense contracting space include General Dynamics (GD), Huntington Ingalls (HII), L3 Technologies (LLL), Lockheed Martin (LMT), Northrop Grumman (NOC) and Raytheon (RTN).
09/21/18
09/21/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. UBS SAYS BUY AT&T: UBS analyst John Hodulik upgraded AT&T (T) to Buy and raised his price target for the shares to $38 from $33, noting that the stock is trading near all-time low valuations and at its widest valuation gap to Verizon (VZ). The Time Warner transaction and accounting changes "have compounded [other] issues, leading to a loss of visibility for investors," but his work indicates that AT&T will return to EBITDA growth in the second half of 2018, after a 6% decline in the first half, due to growth in Wireless and WarnerMedia as well as slower declines in Entertainment. JPMORGAN GOES TO BULL FROM BEAR ON NOVAVAX: JPMorgan analyst Eric Joseph double upgraded Novavax (NVAX) to Overweight from Underweight saying the risk/reward is favorable into the report of Prepare trial data in Q1 of 2019. The trial is assessing the efficacy of the company's RSV F Vaccine for infants via maternal immunization and the analyst believes the shares can hit a range of $2.00 to $2.25, he told investors. JPMORGAN SUGGESTS BEING SHORT COPART, LONG KAR: JPMorgan analyst Ryan Brinkman downgraded Copart (CPRT) to Underweight and lowered his price target for the shares to $47 from $48. The company reported softer than expected Q4 results this week but trades at "near record multiples" of earnings and EBITDA, Brinkman told investors. The analyst sees a potential pair trade in going long KAR Auction (KAR) shares, and short Copart shares, to capitalize on the "valuation disconnect." LOOP SETS $8.25 TARGET ON HARMONIC: Loop Capital analyst James Kisner initiated Harmonic (HLIT) with a Buy rating and $8.25 price target, saying he believes Harmonic can "drive robust revenue growth on its Cable Edge business as cable operators like Comcast (CMCSA, CMCSK) adopt its virtual CCAP/CMTS solution," and that the company's video business with stabilize. 'DON'T PANIC' OVER DOD PROPOSAL: Morgan Stanley analyst Rajeev Lalwani attributes the underperformance in Defense stocks over the last two days compared to the broader market to heightened concerns around a month old proposal from the Department of Defense to adjust progress and performance payments down to 50% from 80% of cost, which would effectively slow the timing of cash flow receipts closer to when a project is complete. He sees a number of reasons not to panic, mainly because he believes that the Administration will not move forward with a proposal industry-players will paint as being anti-business and anti-defense spending. Publicly-traded defense contractors include General Dynamics (GD), Huntington Ingalls (HII), L3 Technologies (LLL), Lockheed Martin (LMT), Northrop Grumman (NOC) and Raytheon (RTN).
10/24/18
STFL
10/24/18
NO CHANGE
Target $200
STFL
Hold
General Dynamics price target lowered to $200 from $210 at Stifel
Stifel analyst Joseph DeNardi lowered his price target for General Dynamics to $200 from $210 following mixed results as revenue guidance softens. The analyst views the supply chain issues affecting General Dynamics as fixable, while demand at Gulfstream and GD's defense business remains healthy. However, General Dynamics is going to be "treated differently by the market relative to its purer-play defense peers when cycle-related selloffs materialize like today," he contends. DeNardi reiterates a Hold rating on the shares.
10/25/18
WELS
10/25/18
NO CHANGE
Target $210
WELS
Outperform
General Dynamics price target lowered to $210 from $250 at Wells Fargo
Wells Fargo analyst Sam Pearlstein lowered his price target for General Dynamics to $210 from $250 due to the overall multiple compression in defense stocks. The analyst believes the stock's post-Q3 sell-off had several causes, including a slight EPS miss, a lower Aerospace backlog, and downward revenue revisions in three segments. Still, Pearlstein believes General Dynamics' core defense business is positioned for solid growth, while Gulfstream volumes should improve as soon as Q4. He reiterates and Outperform rating on the shares.

TODAY'S FREE FLY STORIES

MICT

Micronet Enertec

$0.99

(0.00%)

11:10
05/23/19
05/23
11:10
05/23/19
11:10
Hot Stocks
Micronet Enertec receives two orders totaling $1.3M for SmartHub platform »

MICT announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQT

EQT Corporation

$19.64

-0.31 (-1.55%)

11:10
05/23/19
05/23
11:10
05/23/19
11:10
Hot Stocks
EQT Corporation files definitive proxy, mails letter to shareholders »

EQT Corporation announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTHT

Huazhu Group

$32.60

-1.81 (-5.26%)

11:10
05/23/19
05/23
11:10
05/23/19
11:10
Downgrade
Huazhu Group rating change  »

Huazhu Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

USO

United States Oil Fund

$12.09

-0.66 (-5.18%)

11:10
05/23/19
05/23
11:10
05/23/19
11:10
Options
Customer rolls US Oil ETF puts for 233% gain as oil sells off »

Customer rolls US Oil ETF…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTLR

Rattler Midstream

$0.00

(0.00%)

, FANG

Diamondback Energy

$104.01

-4.86 (-4.46%)

11:09
05/23/19
05/23
11:09
05/23/19
11:09
Syndicate
Rattler Midstream opens at $18.06, IPO priced at $17.50 per share »

Rattler Midstream (RTLR)…

RTLR

Rattler Midstream

$0.00

(0.00%)

FANG

Diamondback Energy

$104.01

-4.86 (-4.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 23

    May

FCX

Freeport McMoRan

$9.94

-0.11 (-1.09%)

11:05
05/23/19
05/23
11:05
05/23/19
11:05
Options
Freeport McMoRan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

IBM

IBM

$132.49

-3.53 (-2.60%)

11:04
05/23/19
05/23
11:04
05/23/19
11:04
Hot Stocks
ProcessMap, IBM announce joint initiative to develop IoT solutions »

ProcessMAP and IBM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

11:04
05/23/19
05/23
11:04
05/23/19
11:04
General news
Kansas City Fed Manufacturing Index Level data reported »

May Kansas City Fed…

LB

L Brands

$24.88

0.59 (2.43%)

10:59
05/23/19
05/23
10:59
05/23/19
10:59
On The Fly
Analysts remain cautious on L Brands despite stronger quarter »

Shares of L Brands (LB)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 22

    Aug

IDYA

IDEAYA Biosciences

$0.00

(0.00%)

10:57
05/23/19
05/23
10:57
05/23/19
10:57
Syndicate
Breaking Syndicate news story on IDEAYA Biosciences »

IDEAYA Biosciences opens…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

CNX

CNX Resources

$7.56

-0.26 (-3.32%)

10:50
05/23/19
05/23
10:50
05/23/19
10:50
Options
Size put option block in CNX after calls bought yesterday »

Size put option block in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

10:50
05/23/19
05/23
10:50
05/23/19
10:50
General news
Treasury Action: yields have extended lower as Wall Street sinks »

Treasury Action: yields…

AZZ

AZZ Inc.

$43.62

(0.00%)

10:46
05/23/19
05/23
10:46
05/23/19
10:46
Hot Stocks
AZZ Inc. discloses change in independent registered public accounting firm »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$39.97

-0.22 (-0.55%)

10:45
05/23/19
05/23
10:45
05/23/19
10:45
Hot Stocks
GSK to change sales representative incentive program »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

10:45
05/23/19
05/23
10:45
05/23/19
10:45
General news
he April U.S. new home sales report beat estimates »

The April U.S. new home…

10:45
05/23/19
05/23
10:45
05/23/19
10:45
General news
Kansas City Fed Manufacturing Index Level to be reported at 11:00 »

May Kansas City Fed…

10:45
05/23/19
05/23
10:45
05/23/19
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

10:45
05/23/19
05/23
10:45
05/23/19
10:45
General news
Breaking General news story  »

3-Month Bill Announcement…

RTLR

Rattler Midstream

$0.00

(0.00%)

10:43
05/23/19
05/23
10:43
05/23/19
10:43
Syndicate
Breaking Syndicate news story on Rattler Midstream »

Rattler Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

XLE

Energy Select Sector SPDR

$61.29

-2.23 (-3.51%)

10:40
05/23/19
05/23
10:40
05/23/19
10:40
Options
Massive ratio put spread in Energy SPDR ETF adjust profitable position »

Massive ratio put spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACAD

Acadia

$24.78

-0.33 (-1.31%)

, ALKS

Alkermes

$24.44

-0.61 (-2.44%)

10:39
05/23/19
05/23
10:39
05/23/19
10:39
Conference/Events
JPMorgan biotech analysts to hold an analyst/industry conference call »

Biotech Analysts Fye,…

ACAD

Acadia

$24.78

-0.33 (-1.31%)

ALKS

Alkermes

$24.44

-0.61 (-2.44%)

ITCI

Intra-Cellular

$13.49

0.41 (3.13%)

NBIX

Neurocrine

$78.73

-1.14 (-1.43%)

SAGE

Sage Therapeutics

$173.51

-1.49 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 05

    Jun

  • 27

    Sep

IDYA

IDEAYA Biosciences

$0.00

(0.00%)

10:37
05/23/19
05/23
10:37
05/23/19
10:37
Syndicate
IDEAYA Biosciences indicated to open at $14, IPO priced at $10 »

IDEAYA Biosciences (IDYA)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

CZR

Caesars

$8.96

-0.155 (-1.70%)

10:35
05/23/19
05/23
10:35
05/23/19
10:35
Options
Caesars put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:30
05/23/19
05/23
10:30
05/23/19
10:30
General news
EIA natural gas storage change for week ending May 17 »

Gas inventories 100 Bcf…

RTLR

Rattler Midstream

$0.00

(0.00%)

10:25
05/23/19
05/23
10:25
05/23/19
10:25
Syndicate
Breaking Syndicate news story on Rattler Midstream »

Rattler Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.